We therefore further examined different macrophage markers (M1; Nitric oxide synthase 2 (NOS2) and M2; CD163 and Heme oxygenase 1 (HMOX1)) in prostates injected with the different tumor EVs. The gene discussed is CD163; the disease is neoplasm.